Pacific Biometrics, a provider of specialty central laboratory services, has been authorized by its Board of Directors to repurchase shares of its common stock up to an aggregate value of $500,000 as part of a new buyback program.

Ron Helm, Chairman and Chief Executive Officer, commented: “It is our opinion that PBI’s current stock price does not accurately reflect the Company’s value, and that the repurchase of the stock is a good strategic use of our resources at this time. The Company has generated record revenues in the first three quarters of the 2006 fiscal year, as reported, and is on track to more than double revenues reported for the 2005 fiscal year. For this reason, we believe a buyback program is consistent with PBI’s growth strategy, and will help enhance shareholder value.”

The shares will be repurchased from time to time in open market transactions at the Company’s discretion, subject to market conditions and other factors. The repurchase program will occur over a period of 12 months through August 31, 2007, and may be modified, extended or discontinued at any time. There is no guarantee as to the exact number of shares that may be repurchased by the Company.

This entry was posted on Wednesday, August 30th, 2006 at 11:36 am and is filed under Corporate. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.